ERTUGLIFLOZIN Called PF-04971729;PF04971729 CAS 1210344-57-2

Ertugliflozin CAS number is1210344-57-2, research code number of PF-04971729 which is a newly developed type of diabetes treatment in SGLT-2 (sodium-glucose co-transporter 2), a new type of diabetes mellitus Target, its mechanism of action is to specifically inhibit renal reabsorption of glucose, and does not depend on the β cell dysfunction or the degree of insulin resistance. The effect of Ertugliflozin will not decline with the function of β cells or severe insulin resistance, will not produce adverse reactions caused by traditional drugs, is a new way to treat diabetes. It was placed with high expectations. Ertugliflozin CAS 1210344-57-2, has a variety of crystal form, but the study of which crystal form is more suitable for oral has become the focus of Ertugliflozin. from the current research results, Ertugliflozin crystal B has obvious advantages than other crystal, Good thermal stability, high solubility, good dissolution, high bioavailability, fully meet the requirements as an oral medication.

Thera. Category:  Anti-diabetes

Cas No.: 1210344-57-2

Synonym:PF-04971729/PF04971729;1, PF 04971729-00;PF-04971729/Ertugliflozin;1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose PF-04971729(Ertugliflozin);Ertugliflozin, >=98%;Ertugliflozin : PF 04971729-00;Leuco methylthioninium

Molecular Formula:C22H25ClO7

Molecular Weight: 436.88

Purity: ≥98.%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Related Intermedaite:
(5-Iodo-2-chlorophenyl) (4-ethoxyphenyl) methanone,cas  1103738-26-6
Ertugliflozin CAS  1210344-57-2,
4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene 1103738-29-9